LBT Innovations Health Care
AI Europe Healthcare Medical North America Pharmaceuticals United Kingdom

$0.030 (0%)

High $0.03	Low $0.03	Trades 25	Turnover $28,362	Volume 960,646
30 June 2023 at 4:10pm

Market Cap (28-Jan) $29,889,572 (1,428th)	Close (30-Jun) $0.030 0 (0%)	Volume (30-Jun) 960,646	Shortsold (12-Dec) 10,096 (0.00%) (692nd)
52w High $0.000	52w Low $0.000	P/E -	EPS 0

Short Interest

ASIC data, 12 Dec 2022

% Shorted

0.00% 0.04

vs 0.04% prior report

Most Shorted Rank

692nd

of 710 shorted ASX stocks

Peak Short

0.40%

Jul 2020

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	LBT LBT Ann: Company Presentation ASX Small and Mid-Cap Conference
	1 (current) 2 3
	LBT LBT Ann: New Data Published on APAS Technology
	LBT LBT Ann: Appendix 4G
	LBT LBT Ann: Corporate Governance Statement
	LBT LBT Ann: Annual Report to shareholders
	LBT LBT Ann: Appendix 4E
	LBT LBT Ann: Application for quotation of securities - LBT
	LBT LBT Ann: Proposed issue of securities - LBT
	LBT LBT Ann: Updated Product Pipeline Strategy Announced
	LBT LBT Ann: Notification of cessation of securities - LBT
	LBT LBT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	LBT LBT Ann: APAS Independence Showcased at Major US Microbiology Conf
	LBT LBT Ann: Direct Sale of APAS Independence in United States
	LBT LBT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	LBT LBT Ann: Clinical Data Featuring APAS Technology Presented at ECCMID
	LBT LBT Ann: Purchase Order for Multiple APAS Instruments
	LBT LBT Ann: Half Yearly Report and Accounts
	LBT LBT Ann: LBT Receives $824,500 R&D Tax Incentive
	LBT LBT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	LBT LBT Ann: Notification regarding unquoted securities - LBT
	LBT LBT Ann: Notification of cessation of securities - LBT
	LBT LBT Ann: LBT Investor Call to discuss CCS Acquisition
	LBT LBT Ann: LBT Completes CCS Acquisition
	LBT LBT Ann: Notice of Initial Substantial Holder
	LBT LBT Ann: LBT Completes CCS Acquisition
	LBT LBT Ann: Appendix 3Y - Simon Arkell
	LBT LBT Ann: Appendix 3Y - Damian Lismore
	LBT LBT Ann: Appendix 3Y - Brian O'Dwyer
	LBT LBT Ann: Appendix 3Y - Joanne Moss
	LBT LBT Ann: Notice under Section 708A - Cleansing Notice
	LBT LBT Ann: Notification regarding unquoted securities - LBT
	LBT LBT Ann: Application for quotation of securities - LBT
	LBT LBT Ann: Update - Proposed issue of securities - LBT
	LBT LBT Ann: Notification regarding unquoted securities - LBT
	LBT LBT Ann: Notification regarding unquoted securities - LBT
	LBT LBT Ann: Application for quotation of securities - LBT
	LBT LBT Ann: Proposed issue of securities - LBT
	LBT LBT Ann: LBT to Obtain Full Ownership of CCS Joint Venture
	LBT LBT Ann: Market Update - Sales Pipeline and Evaluations
	LBT LBT Ann: Results of Meeting
	LBT LBT Ann: CEO Presentation - AGM 2021
	LBT LBT Ann: Chair's Address to Shareholders - AGM 2021
	LBT LBT Ann: Jobkeeper Payments Notification
	LBT LBT Ann: US FDA 510(k) Clearance for MRSA Analysis Module
	LBT LBT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	LBT LBT Ann: Notice of Annual General Meeting/Proxy Form
	LBT LBT Ann: Presentation at Australia Biotech Invest & Partnering 2021
	LBT LBT Ann: SA Government Extends Loan Repayment Schedule
	LBT LBT Ann: Final Director's Interest Notice
	LBT LBT Ann: Kate Costello Retires as Director and Chair of the Board

Similar Companies

Atomo Diagnostics

AT1

Cochlear

COH

CleanSpace Holdings

CSX

Cyclopharm

CYC

EMvision Medical Devices

EMV

Imagion Biosystems

IBX

ImpediMed

IPD

Micro-X

MX1

Respiri

RSH

SomnoMed

SOM

End of Day Prices

Date	Close	Volume	Change
24-Jan	$0.02	893,948	0.00 (5.56%)
23-Jan	$0.02	224,523	0.00 (0.00%)
21-Jan	$0.02	58,463	0.00 (0.00%)
20-Jan	$0.02	30,000	+0.00 (5.88%)
17-Jan	$0.02	1,008,269	0.00 (5.56%)
14-Jan	$0.02	2,762,573	0.00 (5.26%)
13-Jan	$0.02	28,282	0.00 (0.00%)
10-Jan	$0.02	13,488	0.00 (0.00%)
09-Jan	$0.02	536,866	0.00 (5.00%)
08-Jan	$0.02	1,218,817	0.00 (0.00%)
07-Jan	$0.02	633,888	+0.00 (17.65%)
19-Dec	$0.02	40,000	0.00 (0.00%)
18-Dec	$0.02	1,046,928	0.00 (5.56%)
17-Dec	$0.02	557,500	+0.00 (5.88%)
16-Dec	$0.02	304,833	0.00 (0.00%)
3 up, 5 down, and 7 flat days

LBT Innovations Health Care
AI Europe Healthcare Medical North America Pharmaceuticals United Kingdom

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

LBT Innovations Health Care AI Europe Healthcare Medical North America Pharmaceuticals United Kingdom

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

LBT Innovations Health Care
AI Europe Healthcare Medical North America Pharmaceuticals United Kingdom